COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
Bill of Health
JANUARY 12, 2023
By 2009, before Moderna’s patent application, scientists knew that the full-length spike protein is highly immunogenic and can be used to induce protection against certain viruses. Indeed, as made public, the U.S. government committed more than one billion dollars to Moderna for development of its COVID-19 vaccines.
Let's personalize your content